Subjects:
Free Research Articles
On page 762, in the upper graph in Figure 4D, the curves for favorable-risk (Fav) and intermediate/adverse-risk (Int/Adv) patients are reversed because of an error that occurred during the publication process. The corrected Figure 4D is shown below.
Figure 4.
Outcome of patients with DDX41MutGL compared with DDX41WT AML. (D) Cumulative incidence of relapse (top) and death (bottom) censored at HSCT in CR1 in DDX41MutGL and DDX41WT AML.
Figure 4.
Outcome of patients with DDX41MutGL compared with DDX41WT AML. (D) Cumulative incidence of relapse (top) and death (bottom) censored at HSCT in CR1 in DDX41MutGL and DDX41WT AML.
© 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2025
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal